Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says

Takeda is helping Moderna and Novavax make their COVID-19 vaccines available in Japan. With those new products and about a decade’s worth of progress on its dengue shot under its belt, Takeda's CEO sees vaccines becoming a bigger part of the drugmaker’s business going forward.